Annabel Y. Chee
Melbourne, VIC 3010, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Evaluating skeletal muscle dysfunction and recovery in a zymosan model of critical illness in mice.
Journal: Disease models & mechanisms
Published: October 17, 2025
FcRn: A novel target to attenuate rheumatoid cachexia in arthritic mice.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: October 02, 2025
Intrinsic muscle stem cell dysfunction underlies functional deficits in models of type 1 diabetes.
Journal: NPJ Regenerative medicine
Published: July 06, 2025
Altering phosphorylation of dystrophin S3059 to attenuate cancer cachexia.
Journal: Life sciences
Published: October 24, 2024
Dystrophin S3059 phosphorylation partially attenuates denervation atrophy in mouse tibialis anterior muscles.
Journal: Physiological reports
Published: April 08, 2024
The BALB/c.mdx62 mouse exhibits a dystrophic muscle pathology and is a model of Duchenne muscular dystrophy.
Journal: Disease models & mechanisms
Published: September 10, 2023
Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer.
Journal: NPJ precision oncology
Published: September 09, 2022
Phosphorylation of ERK and dystrophin S3059 protects against inflammation-associated C2C12 myotube atrophy.
Journal: American journal of physiology. Cell physiology
Published: March 17, 2021
Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice.
Journal: Scientific reports
Published: January 09, 2019
Deletion of suppressor of cytokine signaling 3 (SOCS3) in muscle stem cells does not alter muscle regeneration in mice after injury.
Journal: PloS one
Published: October 15, 2018
Mas Receptor Activation Slows Tumor Growth and Attenuates Muscle Wasting in Cancer.
Journal: Cancer research
Published: April 19, 2018
Last Updated: 09/26/2026